Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis
Phase 3
Completed
- Conditions
- Central Neuropathic Pain in Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-08-14
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Bionorica Research GmbH
- Target Recruit Count
- 240
- Registration Number
- NCT00959218
- Locations
- 🇩🇪
Maerkische Kliniken GmbH, Klinikum Luedenscheid, Akademisches Lehrkrankenhaus der Universitaet Bonn, Klinik fuer Neurologie, Luedenscheid, Germany
© Copyright 2025. All Rights Reserved by MedPath